Stock Taper Organic Sales Growth: 1.2% year-to-date, with Q3 performance at 1.0%.
Net Sales: Expected to grow low single digits for the full year, in line with year-to-date performance.
Gross Margin: Down year-over-year, primarily due to raw material inflation, particularly in fats and oils. Q3 gross margin was impacted by the Colgate Total formula change, resulting in a 40-50 basis point hit.
Earnings Per Share (EPS): Guidance maintained for low single-digit growth, reflecting resilience despite headwinds.
2030 Strategy: Transitioning from the 2025 plan to a focus on accelerating growth through enhanced innovation, omnichannel strategies, and AI integration.
Innovation Model: Increased investment in science-based innovation across price tiers, leveraging AI for faster product development and consumer engagement.
Revenue Growth Management (RGM): Enhanced focus on analytics to optimize pricing and product offerings.
Supply Chain Improvements: Utilization of predictive analytics and automation to enhance efficiency and service levels.
Q4 Expectations: Anticipated improvement in organic sales growth, driven by stabilization in inventory levels and the impact of the Colgate Total relaunch.
Long-term Growth: Confidence in the ability to outperform in a sluggish market, particularly in emerging markets and through strong brand health.
Market Conditions: Ongoing consumer uncertainty, geopolitical tensions, and inflationary pressures are impacting sales and profitability.
Category Softness: Declining metrics in several markets, particularly in North America and Europe, with expectations for continued sluggishness into 2026.
Hill's Performance: Mixed results with a noted decline in volume mix; however, market share remains strong in certain segments.
Latin America Issues: A decline in oral care sales due to trade inventory adjustments and consumer complaints related to the Colgate Total formula change.
Category Growth Outlook: Executives expect continued sluggishness in category growth, particularly in developed markets, with a shift towards premium products.
Competitive Environment: Increased promotional activity noted, but still rational compared to pre-COVID levels. Focus on innovation to stimulate demand.
China Market Dynamics: Challenges with the H&H subsidiary, with a shift towards e-commerce strategies and premium product offerings to regain market share.
Pet Care Segment: Despite category softness, Hill's is gaining share in strategic segments, with a focus on therapeutic products driving growth.
Advertising Strategy: Continued robust spending on advertising, with a focus on leveraging AI for improved efficiency and effectiveness. Overall, Colgate-Palmolive is navigating a challenging environment with strategic initiatives aimed at enhancing growth and operational efficiency while addressing market-specific challenges.
SOURCE: Q3 2025 EARNINGS CALL TRANSCRIPT